Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab

Among the IL-6 inhibitors, tocilizumab is the most widely used therapeutic option in patients with SARS-CoV-2-associated severe respiratory failure (SRF). The aim of our study was to provide evidence on predictors of poor outcome in patients with COVID-19 treated with tocilizumab, using machine lear...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramón, Antonio, Zaragozá, Marta, Torres, Ana María, Cascón, Joaquín, Blasco, Pilar, Milara, Javier, Mateo, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410189/
https://www.ncbi.nlm.nih.gov/pubmed/36012968
http://dx.doi.org/10.3390/jcm11164729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410189/
https://www.ncbi.nlm.nih.gov/pubmed/36012968
http://dx.doi.org/10.3390/jcm11164729

Ejemplares similares